IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Chinook Therapeutics CVR (KDNY)

CUSIP: 169CVR016 | 9 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Ascentis Independent Advisors30
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Ascentis Independent Advisors
30$00.0%GrowthLowDallas, TX2026-11-03